Travis Pagliara, MD
Urology · Minneapolis, MNNPI 1942597208
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $37,925 of the $52,512 with a category attached, or 72.2%. Boston Scientific accounts for 92.2% of it on its own, with 7 other manufacturers making up the rest. 2025 is the largest year on record at $14,962, 3.5 times the $4,302 reported in 2019. Among urology clinicians in MN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 70 payments — averaging $750.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$48K
- Coloplast$2K
- Gyrus ACMI, Inc.$2K
- Calyxo, Inc.$213
- AstraZeneca$35
- Axonics, Inc.$34
- plus $38 from 2 others
What the payments were for
- Consulting fees$13,63826%
- Speaking & faculty fees$37,92572%
- Food & beverage$9032%
- Education$470%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 55 | $48,437 |
| Coloplast | 7 | $2,255 |
| Gyrus ACMI, Inc. | 1 | $1,500 |
| Calyxo, Inc. | 2 | $213 |
| AstraZeneca | 1 | $35 |
| Axonics, Inc. | 2 | $34 |
| Laborie Medical Technologies Corp. | 1 | $26 |
| Urogen Pharma, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GENERAL ERECTILE DYSFUNCTION$14,900
- AdVance XP$6,200
- AMS 700 CXR RTE KIT$5,800
- AMS$5,013
- ADVANCE$2,100
- TITAN$2,050
- AMS 700$2,000
- AMS 800 Artificial Urinary Sphincter$1,600
- LithoVue$800
- UROMAX ULTRA$400
- CVAC Aspiration System$115
How this compares
$52,512 in reported general payments places this provider in the 90th percentile of 247 urology providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 46 | $23,110 |
| Trospium Chloride ErTrospium Chloride | 19 | $1,965 |
| Finasteride | 59 | $554 |
| Tamsulosin Hcl | 56 | $539 |
| Solifenacin Succinate | 13 | $135 |
| Levofloxacin | 11 | $120 |
| Oxycodone Hcl | 36 | $87 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 20 | $80 |
Paid to pharmacies, not to this prescriber.
Other urology in Minneapolis
- Ayman SoubraMinneapolis$204K
- Sean ElliottMinneapolis$163K
- Nissrine NakibMinneapolis$86K
- Badrinath KonetyMinneapolis$45K
- Christopher WeightMinneapolis$16K
- James AndersonMinneapolis$5K
- Joseph AcquayeMinneapolis$4K
- Joseph PariserMinneapolis$4K
- David YangMankato$298K
- Steven BernsteinEdina$271K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.